Jordan vs Suriname: Cause of death, by non-communicable diseases, ages 5-14, female
Jordan
41.8%
in 2021
Suriname
39.9%
in 2021
Jordan rank
86th
Suriname rank
89th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Jordan
- Suriname
How they compare
Jordan currently reports 41.8% against 39.9% in Suriname, a difference of 1.9%.
Across all 6 years both countries report, Jordan has been ahead every year.
Jordan ranks 86th and Suriname ranks 89th of 184 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.3% | 32.7% | 16.6% | Jordan |
| 2010s | 46.9% | 38.2% | 8.6% | Jordan |
| 2020s | 44.7% | 40.7% | 4.0% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Jordan or Suriname?
- Jordan, at 41.8% against 39.9% in Suriname as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Jordan and Suriname?
- 1.9%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Jordan and Suriname rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Jordan ranks 86th and Suriname ranks 89th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.